$29.11
3.64% yesterday
Nasdaq, Nov 15, 10:02 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock News

Neutral
Business Wire
2 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 233,603 shares of its common stock to 123 new non-executive employees and non-qualified stock option awards to purc...
Positive
The Motley Fool
3 days ago
The rock star money manager is starting to roll with the rallying market.
Positive
Investors Business Daily
9 days ago
Guardant Health stock jumped Thursday on an "impressive" third-quarter report following the launch of its cancer detection test, Shield. The post Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop appeared first on Investor's Business Daily.
Neutral
Seeking Alpha
9 days ago
Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
9 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Recorded revenue of $191.5 million for the third quarter of 2024, an increase of 34% over the third quarter of 2023 Reported 53,100 clinical tests (excluding Shield) and 10...
Neutral
Business Wire
15 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences. ●   Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA     Fireside chat on Tuesday, November 12 at 10:30 a.m. Eastern Time       ●   Wolfe Healthcare Conference in New York, NY     Host...
Neutral
The Motley Fool
16 days ago
There's nothing like free publicity to help goose the sales of a relatively new product.
Neutral
Business Wire
17 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the inclusion of its blood-based colorectal cancer screening product Shield in TIME's annual list of the Best Inventions, which features 200 extraordinary innovations changing lives. To compile this year's list, TIME solicited nominations from TIME editors and correspond...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today